TRIANA BIOMEDICINES
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
TRIANA BIOMEDICINES
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.trianabio.com
Total Employee:
11+
Status:
Active
Contact:
617-778-2572
Total Funding:
160.8 M USD
Technology used in webpage:
Squarespace Hosted
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Swiftscale Biologics
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Triana Biomedicines
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series A - Triana Biomedicines
RA Capital Management
RA Capital Management investment in Series A - Triana Biomedicines
Logos Capital
Logos Capital investment in Series A - Triana Biomedicines
Surveyor Capital
Surveyor Capital investment in Series A - Triana Biomedicines
Atlas Venture
Atlas Venture investment in Series A - Triana Biomedicines
Key Employee Changes
| Date | New article |
|---|---|
| 2023-09-12 | TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer |
Official Site Inspections
http://www.trianabio.com Semrush global rank: 7.77 M Semrush visits lastest month: 720
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Triana Biomedicines"
Triana Biomedicines - Crunchbase Company Profile
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality.See details»
TRIANA Biomedicines - LinkedIn
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel small molecules to treat disease.See details»
TRIANA Biomedicines 2025 Company Profile: Valuation, Funding ...
TRIANA Biomedicines General Information Description. Operator of a pharmaceutical company intended to discover and develop molecular glues. The company leverages technology to …See details»
Triana Biomedicines - Press Release 9/12/23 VitoReza
Sep 12, 2023 Prior to joining TRIANA, he was the Chief Scientific Officer (CSO) at Surface Oncology, where he led the non-clinical research and development organization. Prior to that, …See details»
TRIANA Biomedicines - Overview, News & Similar companies
Apr 9, 2022 TRIANA Biomedicines contact info: Phone number: (781) 317-4414 Website: www.trianabio.com What does TRIANA Biomedicines do? Founded in 2019 and based in …See details»
TRIANA Biomedicines Announces the Appointments of Vito
Sep 12, 2023 Prior to joining TRIANA, he was the Chief Scientific Officer (CSO) at Surface Oncology, where he led the non-clinical research and development organization. Prior to that, …See details»
TRIANA Biomedicines - Craft
TRIANA Biomedicines has 5 employees at their 1 location and $144.8 m in total funding,. See insights on TRIANA Biomedicines including office locations, competitors, revenue, financials, …See details»
Triana Biomedicines - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Triana Biomedicines, Inc. | Insights
Https://trianabio.com. Industry. Pharmaceuticals; Digital Health. Artificial Intelligence; Biotechnology. Drug Discovery Technologies; See more in Biomedtracker. Latest on Triana …See details»
Matchmaking for proteins: Introducing TRIANA …
April 6, 2022. In the past two decades, targeted protein degradation (TPD) has evolved from a novel concept to a new therapeutic modality. Last October, I wrote about the history and progression of the TPD space.Readers might have …See details»
TRIANA Biomedicines - Lightspeed Venture Partners
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel therapeutics to treat diseases.See details»
TRIANA Biomedicines’ Post - LinkedIn
Delighted to officially welcome the newest members to TRIANA! So excited to have Vito Palombella and Reza Mazhari as members of our leadership team. Welcome… | 14 …See details»
TRIANA Biomedicines Launches With $110M to Unlock the Full …
Apr 6, 2022 Organization: PRI Release Summary TRIANA Biomedicines launches with $110M in funding to establish a best-in-class, scalable platform to discover and develop "molecular glues."See details»
Triana Biomedicines - Science
Protein:protein pairing engine: We are using a multilayered approach, inclusive of artificial intelligence as well as experimental approaches to prioritize a short list of E3 Ligases out of …See details»
Triana Biomedicines - workinbiotech.com
Triana Biomedicines is using technology to identify “molecular glues” which are small molecules that interact with a disease target protein to change its function. This approach allows for the …See details»
Triana Biomedicines - Press Release 9/19/2022
Sep 19, 2022 Contact Open Menu Close Menu Close MenuSee details»
TRIANA Biomedicines’ Post - LinkedIn
Learn more about TRIANA Biomedicines from our CEO Patrick Trojer, PhD and his conversation with Paul Schloesser at Endpointsnews: https://lnkd.in/dz8BQSGnSee details»
Press Release 4/6/2022 - Triana Biomedicines
Apr 6, 2022 [email protected]. TRIANA Biomedicines, Inc. 1050 Waltham Street, Suite 301 Lexington, MA 02421 ...See details»
Enara Bio Strengthens Senior Leadership with Key Executive and …
4 days ago Oxford, United Kingdom – May 01, 2025.Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and …See details»
Triana Biomedicines - Press Release 6/23/2022
Jun 23, 2022 [email protected]. TRIANA Biomedicines, Inc. 1050 Waltham Street, Suite 301 Lexington, MA 02421 ...See details»